RxDoctor Payments Data

Debra de Angelo, DO

Anesthesiology · Gettysburg, PANPI 1083689301

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Boston Scientific at 24.4% of the total. Reporting peaked in 2019 at $443 and has fallen 89.6% since, to $46 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$937in general payments, 2019–2025

Across 69 payments — averaging $13.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$228
  • Collegium Pharmaceutical, Inc.$196
  • AbbVie$87
  • Biodelivery Sciences International, Inc.$69
  • Abbott$68
  • Pfizer$63
  • plus $226 from 11 others

What the payments were for

  • Food & beverage$937100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$937 in reported general payments places this provider in the 90th percentile of 2,015 anesthesiology providers in Pennsylvania.

See all anesthesiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$20,051
Medicare patients
205
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin75$915

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Gettysburg

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →